ArticleCancer medicine2021

SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis.

Yang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.